Related Experiment Video

Updated: May 18, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass surgery: a

Michel Pompeu B O Sá1, Paulo E Ferraz, Rodrigo R Escobar

  • 1Division of Cardiovascular Surgery of Pronto Socorro Cardiológico de Pernambuco - PROCAPE, Recife, Pernambuco, Brazil. michel_pompeu@yahoo.com.br

Coronary Artery Disease
|September 8, 2012
PubMed

Insights

Prophylactic use of intra-aortic balloon pumps (IABP) significantly reduces hospital mortality and low cardiac output syndrome in high-risk patients undergoing coronary artery bypass graft surgery. This intervention also shortens intensive care unit and hospital stays.

Area of Science:

  • Cardiovascular Surgery
  • Critical Care Medicine
  • Medical Device Technology

Background:

  • Coronary artery bypass graft (CABG) surgery carries significant risks for high-risk patients.
  • Prophylactic use of intra-aortic balloon pump (IABP) is a potential strategy to mitigate these risks.
  • Evidence on the efficacy of prophylactic IABP in CABG is debated.

Purpose of the Study:

  • To assess the efficacy of prophylactic intra-aortic balloon pump (IABP) in high-risk patients undergoing coronary artery bypass graft (CABG) surgery.
  • To evaluate the impact of prophylactic IABP on hospital mortality, postoperative low cardiac output syndrome, and length of stay.
  • To synthesize evidence from randomized controlled trials (RCTs) through meta-analysis.

Main Methods:

  • Comprehensive literature search across multiple databases (MEDLINE, EMBASE, CENTRAL, etc.) and reference lists.
  • Inclusion of only randomized controlled trials (RCTs) with duplicate assessment for eligibility, relevance, and data extraction.
  • Meta-analysis performed using both fixed-effect and random-effect models to determine pooled relative risks and mean differences.

Main Results:

  • Seven RCTs involving 345 patients (177 prophylactic IABP, 168 control) were included.
  • Prophylactic IABP significantly reduced hospital mortality (RR 0.255, P<0.001) and postoperative low cardiac output syndrome (RR 0.206, P<0.001).
  • Patients receiving prophylactic IABP experienced shorter intensive care unit and hospital stays (P<0.001), with minimal insertion site complications (7.4%) and no IABP-related deaths.

Conclusions:

  • This meta-analysis provides strong evidence supporting the use of prophylactic intra-aortic balloon pump (IABP) in high-risk patients undergoing CABG.
  • Prophylactic IABP is associated with significant reductions in hospital mortality and postoperative complications.
  • The findings suggest that prophylactic IABP is a safe and effective strategy to improve outcomes in this patient population.
Abstract